与严重的α-1抗素缺乏相关的肺气增强疗法的个性化指示:一个病例系列
Cristina Aljama1, Teresa Martin2, Galo Granados1
1Pneumology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
Therapeutic advances in respiratory disease
|August 12, 2024
概括
严重的α-1抗素缺乏症 (AATD) 呈现异质症状,使得预后变得困难. 增强疗法决策需要个性化评估,平衡风险和益处,以获得最佳的患者护理.
科学领域:
- 肺部病理学 肺部病理学
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的α-1抗素缺乏症 (AATD) 增加了肺气风险,但呈现出不同的临床表现.
- 由于异质的表现,AATD的个体预后具有挑战性.
- 静脉注射α-1抗素 (AAT) 增强是唯一的特异性治疗方法,需要终身使用.
研究的目的:
- 为了解决启动AAT增强疗法的临床困境.
- 为了突出专家之间治疗指示的变化.
- 强调需要个性化以患者为中心的决策.
主要方法:
- 案例研究分析,说明AATD治疗决策.
- 从正常肺功能到疾病进展的临床情景的审查.
- 讨论AAT增强疗法指示中的细微差别.
主要成果:
- 对AAT增强的临床决策是复杂的,没有一种适合所有人的方法.
- 关于何时开始治疗,专家之间存在差异.
- 个性化评估,考虑利弊至关重要.
结论:
- 启动AAT增强疗法需要对患者因素进行仔细,个性化的考虑.
- 在AATD管理方面有经验的参考中心对于最佳决策至关重要.
- 协作护理模型可以改善患者的舒适性和治疗坚持.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
191
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
191
COPD: Management Using Bronchodilators and Corticosteroids
192
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
192
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
147
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
147
Acute Respiratory Failure-V
126
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
126
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K


